It also discussed the potential role of omalizumab in combination with specific allergen immunotherapy and other potential indications for omalizumab in IgE-mediated disorders, including food allergy, latex allergy, atopic dermatitis, and chronic urticaria. Here, IGHE is linked to food allergy.